OICR Investigators

OICR's Investigator Awards Program has attracted outstanding PhD researchers and clinician-scientists to Ontario from across Canada and around the world. The program provides stable recruitment and retention funding for principal investigators in Ontario, further strengthening the province’s cancer research capacity.

CAREERS@OICR

To learn more about OICR's job opportunities, please visit our Careers page.

Sort by:
  • LaurieAilles

    Dr. Laurie Ailles

    OICR Investigator II

    A tumour is a mass of cells that grows uncontrollably and eventually spreads throughout the body. A small ...

  • RimaAl-awar

    Dr. Rima Al-awar

    Director and Senior Principal Investigator, Drug Discovery Program

    Since joining OICR, Dr. Al-awar has been recruiting scientists and developing the Drug Discovery Program ...

  • AnitaBane

    Dr. Anita Bane

    Clinician-Scientist II

    Dr. Anita Bane's research interests involve the identification and validation of prognostic and predictive ...

  • JohnBartlett

    Dr. John Bartlett

    Program Director, Transformative Pathology

    Dr. John Bartlett is pursuing an integrated platform of research focused on the development of novel cancer ...

  • NizarBatada

    Dr. Nizar Batada

    OICR Investigator II

    Genome instability, stem cell biology and cancer. How does a normal cell suddenly embark on a journey ...

  • JohnBell

    Dr. John Bell

    Program Director, Immuno- and Bio-Therapeutics

    Using viruses to kill cancer cells is a promising alternative to chemotherapy because it dramatically reduces ...

  • PaulBoutros

    Dr. Paul Boutros

    OICR Investigator I

    Today, most cancer patients are treated based on physical characteristics of their tumour -- usually how ...

  • JanetDancey

    Dr. Janet Dancey

    Program Director, High Impact Clinical Trials

    Dr. Janet Dancey is the leader of the High Impact Clinical Trials program at OICR and the Director of ...

  • JohnDick

    Dr. John Dick

    Program Director, Cancer Stem Cells Program

    Dr. John Dick and his team investigate the genetic programs that control human blood stem cells (HSCs) to ...

  • CraigEarle

    Dr. Craig Earle

    Program Director, Health Services Research

    The purpose of the OICR Health Services Research Program is to enhance Ontario’s capacity to study the ...

  • AaronFenster

    Dr. Aaron Fenster

    Co-Program Director, Imaging Translation Program
    Co-Program Director, Smarter Imaging Program

    The Imaging Translation Program, led by Dr. Aaron Fenster and Dr. Martin Yaffe, is a key component of ...

  • VincentFerretti

    Dr. Vincent Ferretti

    OICR Senior Investigator and Associate Director, Bioinformatics Software Development

    Dr. Vincent Ferretti's expertise is in bioinformatics with experience in both large-scale software ...

  • GeoffreyFong

    Dr. Geoffrey Fong

    OICR Senior Investigator

    While advances in early cancer detection and treatment have led to improved cancer outcomes for patients, ...

  • RebeccaGladdy

    Dr. Rebecca Gladdy

    Clinician-Scientist I

    Soft tissue sarcomas (STS) are a diverse group of tumours derived from connective tissue (muscle, fat and ...

  • EvaGrunfeld

    Dr. Eva Grunfeld

    Clinician-Scientist I

    The focus of Dr. Grunfeld’s research is the evaluation of access to and quality of cancer care across the ...

  • MasoomHaider

    Dr. Masoom Haider

    Clinician-Scientist II

    Dr. Haider’s major research focus is abdominal and pelvic magnetic resonance imaging (MRI) with a special ...

  • TimothyHanna

    Dr. Timothy Hanna

    Clinician-Scientist I

    Radiation therapy is an important part of cancer therapy. Dr. Hanna is currently developing models estimating ...

  • NaotoHirano

    Dr. Naoto Hirano

    Clinician-Scientist II

    The overarching goal of Dr. Hirano's research is to devise novel anti-tumour immunotherapeutic modalities ...

  • KristinHope

    Dr. Kristin Hope

    OICR Investigator I

    Dr. Kristin Hope’s research program is focused on dissecting the molecular regulation of hematopoietic stem ...

  • TomHudson

    Dr. Tom Hudson

    President and Scientific Director

    As President and Scientific Director of the Ontario Institute for Cancer Research (OICR), Dr. Tom Hudson is ...

  • RosalynJuergens

    Dr. Rosalyn Juergens

    Clinician-Scientist II

    Dr. Juergens’ clinical expertise is in lung and esophageal cancer. Her areas of research expertise involve ...

  • Shyh-DarLi

    Dr. Shyh-Dar Li

    OICR Investigator I

    Dr. Li is interested in developing nanoparticles that target payloads (therapeutic molecules and imaging ...

  • MathieuLupien

    Dr. Mathieu Lupien

    OICR Investigator II

    Dr. Mathieu Lupien is a scientist at the Princess Margaret Cancer Center and holds a cross-appointment with ...

  • JohnMcPherson

    Dr. John McPherson

    Genome Technologies Director

    New sequencing technologies have made possible the systematic identification of genetic mutations and other ...

  • BrianNieman

    Dr. Brian Nieman

    OICR Investigator I

    As success with treating pediatric brain cancers has grown, it has also become clear that there are ...

  • DavidPalma

    Dr. David Palma

    Clinician-Scientist II

    The technology available for treating cancer with radiation is changing rapidly - over the last 10 years ...

  • Paul C.Park

    Dr. Paul C. Park

    OICR Investigator

    Epithelial-Mesenchymal Transition (EMT) is a molecular program that drives a phenotypic cross-lineage ...

  • BretPearson

    Dr. Bret Pearson

    OICR Investigator I

    Despite intense research involving embryonic stem cells, relatively little is known about how adult stem ...

  • RobertRottapel

    Dr. Robert Rottapel

    Program Director, Innovation in Target Validation

    The Terry Fox Research Institute offers an exciting new model for cancer research, a virtual institute to ...

  • TimothyScholl

    Dr. Timothy Scholl

    OICR Investigator I

    As cancer treatments become more individualized, molecular imaging is becoming an increasingly valuable tool ...

  • SachdevSidhu

    Dr. Sachdev Sidhu

    OICR Senior Investigator

    How cells grow and how they work depends on signals that are mediated by interactions among proteins in the ...

  • LincolnStein

    Dr. Lincoln Stein

    Program Director

    Dr. Lincoln Stein leads the OICR's Informatics and Bio-computing Program, which undertakes the management and ...

  • RosieThein

    Dr. Rosie Thein

    OICR Investigator I

    Dr. Thein is interested in infectious disease and cancer research, and mathematical modeling methods for ...

  • BradWouters

    Dr. Brad Wouters

    OICR Senior Investigator

    Unlike most tissue, tumour cells can survive and thrive in environments starved of oxygen. Characterized by ...

  • MartinYaffe

    Dr. Martin Yaffe

    Co-Program Director, Smarter Imaging Program
    Co-Program Director, Imaging Translation Program

    Early diagnosis and detection of a tumour before it grows and spreads is critical in surviving cancer. In ...

  • ZZZZZZ
NameRole
Dr.LaurieLaurieAillesAilles
Laurie Ailles, OICR Investigator II, Ontario Institute for Cancer Research (OICR)
Dr.RimaRimaAl-awarAl-awar
Rima Al-awar, Director and Senior Principal Investigator, Drug Discovery Program, Ontario Institute for Cancer Research (OICR)
Dr.AnitaAnitaBaneBane
Anita Bane, Clinician-Scientist II, Ontario Institute for Cancer Research (OICR)
Dr.JohnJohnBartlettBartlett
John Bartlett, Program Director, Transformative Pathology, Ontario Institute for Cancer Research (OICR)
Dr.NizarNizarBatadaBatada
Nizar Batada, OICR Investigator II, Ontario Institute for Cancer Research (OICR)
Dr.JohnJohnBellBell
John Bell, Program Director, Immuno- and Bio-Therapeutics, Ontario Institute for Cancer Research (OICR)
Dr.PaulPaulBoutrosBoutros
Paul Boutros, OICR Investigator I, Ontario Institute for Cancer Research (OICR)
Dr.JanetJanetDanceyDancey
Janet Dancey, Program Director, High Impact Clinical Trials, Ontario Institute for Cancer Research (OICR)
Dr.JohnJohnDickDick
John Dick, Program Director, Cancer Stem Cells Program, Ontario Institute for Cancer Research (OICR)
Dr.CraigCraigEarleEarle
Craig Earle, Program Director, Health Services Research, Ontario Institute for Cancer Research (OICR)
Dr.AaronAaronFensterFenster
Aaron Fenster, Co-Program Director, Imaging Translation Program, Ontario Institute for Cancer Research (OICR);
Aaron Fenster, Co-Program Director, Smarter Imaging Program, Ontario Institute for Cancer Research (OICR)
Dr.VincentVincentFerrettiFerretti
Vincent Ferretti, OICR Senior Investigator and Associate Director, Bioinformatics Software Development , Ontario Institute for Cancer Research (OICR)
Dr.GeoffreyGeoffreyFongFong
Geoffrey Fong, OICR Senior Investigator, Ontario Institute for Cancer Research (OICR)
Dr.RebeccaRebeccaGladdyGladdy
Rebecca Gladdy, Clinician-Scientist I, Ontario Institute for Cancer Research (OICR)
Dr.EvaEvaGrunfeldGrunfeld
Eva Grunfeld, Clinician-Scientist I, Ontario Institute for Cancer Research (OICR)
Dr.MasoomMasoomHaiderHaider
Masoom Haider, Clinician-Scientist II, Ontario Institute for Cancer Research (OICR)
Dr.TimothyTimothyHannaHanna
Timothy Hanna, Clinician-Scientist I, Ontario Institute for Cancer Research (OICR)
Dr.NaotoNaotoHiranoHirano
Naoto Hirano, Clinician-Scientist II, Ontario Institute for Cancer Research (OICR)
Dr.KristinKristinHopeHope
Kristin Hope, OICR Investigator I, Ontario Institute for Cancer Research (OICR)
Dr.TomTomHudsonHudson
Tom Hudson, President and Scientific Director, Ontario Institute for Cancer Research (OICR)
Dr.RosalynRosalynJuergensJuergens
Rosalyn Juergens, Clinician-Scientist II, Ontario Institute for Cancer Research (OICR)
Dr.Shyh-DarShyh-DarLiLi
Shyh-Dar Li, OICR Investigator I, Ontario Institute for Cancer Research (OICR)
Dr.MathieuMathieuLupienLupien
Mathieu Lupien, OICR Investigator II, Ontario Institute for Cancer Research (OICR)
Dr.JohnJohnMcPhersonMcPherson
John McPherson, Genome Technologies Director, Ontario Institute for Cancer Research (OICR)
Dr.BrianBrianNiemanNieman
Brian Nieman, OICR Investigator I, Ontario Institute for Cancer Research (OICR)
Dr.DavidDavidPalmaPalma
David Palma, Clinician-Scientist II, Ontario Institute for Cancer Research (OICR)
Dr.Paul C.Paul C.ParkPark
Paul C. Park, OICR Investigator, Ontario Institute for Cancer Research (OICR)
Dr.BretBretPearsonPearson
Bret Pearson, OICR Investigator I, Ontario Institute for Cancer Research (OICR)
Dr.RobertRobertRottapelRottapel
Robert Rottapel, Program Director, Innovation in Target Validation, Ontario Institute for Cancer Research (OICR)
Dr.TimothyTimothySchollScholl
Timothy Scholl, OICR Investigator I, Ontario Institute for Cancer Research (OICR)
Dr.SachdevSachdevSidhuSidhu
Sachdev Sidhu, OICR Senior Investigator, Ontario Institute for Cancer Research (OICR)
Dr.LincolnLincolnSteinStein
Lincoln Stein, Program Director, Ontario Institute for Cancer Research (OICR)
Dr.RosieRosieTheinThein
Rosie Thein, OICR Investigator I, Ontario Institute for Cancer Research (OICR)
Dr.BradBradWoutersWouters
Brad Wouters, OICR Senior Investigator, Ontario Institute for Cancer Research (OICR)
Dr.MartinMartinYaffeYaffe
Martin Yaffe, Co-Program Director, Smarter Imaging Program, Ontario Institute for Cancer Research (OICR);
Martin Yaffe, Co-Program Director, Imaging Translation Program, Ontario Institute for Cancer Research (OICR)